The Key Laboratory for Endocrine-Related Cancer Precision Medicine of Xiamen began to be set up in 2017. In November 2019, it  passed the acceptance check and was officially established.

Relying on the research resource-sharing platform of Xiamen University, the Key Laboratory has a research area of about 2,000 square meters, and the total expenditure for laboratory construction and operation in the past three years is more than 30 million yuan. The research team building focuses on collaboration between the basic and the clinical, also covers many related disciplines such as medical imaging, oncology, molecular biology, internal medicine, surgery and pharmacy. There are currently 29 permanent staff in our laboratory, of whom nearly 50% have senior titles and PhD, including one Chair Professor of Cheung Kong Scholars Programme and two in Xiamen "Double Hundred Talents Program". The key members have many years of overseas education backgrounds and work experiences.

Supported by molecular imaging technology, the key laboratory lays emphasis on five research directions:

First, molecular mechanism and markers of the genesis and development of endocrine-related cancers;

Second, development and application of anti-endocrine-related cancers drugs;

Third, navigation guided by multimodal molecular imaging technology in endocrine-related tumors surgeries;

Fourth, application of photoacoustic imaging technology in early diagnosis, monitoring of endocrine-related tumors;

Fifth, application of multimodal molecular imaging technology combined with artificial intelligence in the precise diagnosis and treatment of endocrine-related tumors.

Adhering to the operation mechanism of "open, mobile, joint and competitive", we constantly establish and improve management systems and innovation mechanisms, strive to build the laboratory into a domestic leading research institution in the field of endocrine-related tumors and help the strategy of "Healthy China, Healthy Xiamen".